HOT NEWS
Pfizer
PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit www.pfizer.com.

Pfizer RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Pfizer's Vyndaqel® (tafamidis) First Therapy Approved in the European Union 2459
2 Pfizer Receives European Approval to Extend Use of Prevenar 13 2981
3 Pfizer Announces EMA Acceptance of Regulatory Submissions 4040
4 Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography 5490
5 Pfizer Files for European Regulatory Review of Axitinib 5639
6 ELIQUIS® (apixaban) Approved in Europe for Preventing Venous Thromboembolism after Elective Hip or Knee Replacement 6696
7 Pfizer Reports First-Quarter 2011 Results 5246
8 XIAPEX® Authorized in the European Union (EU) for Dupuytren's Contracture 9399
9 New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin 8063
10 Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization 7820
11 Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity 6868
12 Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent 6015
13 Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need 6012
14 Pfizer Reports Second-Quarter 2010 Results 5827
15 New CELEBREX® (celecoxib) Study Using Novel Endpoint 5950
16 Phase 3 Study Showed MACUGEN® Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema 5443
17 Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon 4790
18 New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas 4812
19 Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEX 4949
20 European Commission Approves New Intravenous Formulation Of Pfizer's Revatio® 3138
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share